Inhibition of Human Cytochrome P450‐3A Isoforms by Fluoxetine and Norfluoxetine: In Vitro and In Vivo Studies
Open Access
- 1 September 1996
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 36 (9) , 792-798
- https://doi.org/10.1002/j.1552-4604.1996.tb04252.x
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Relationship of In Vitro Data on Drug Metabolism to In Vivo Pharmacokinetics and Drug InteractionsJournal of Clinical Psychopharmacology, 1996
- The Clinician and Drug Interactions-An UpdateJournal of Clinical Psychopharmacology, 1996
- Inhibition of Alprazolam and Desipramine Hydroxylation In Vitro by Paroxetine and FluvoxamineJournal of Clinical Psychopharmacology, 1995
- Steady-State Kinetics of Fluoxetine and Amitriptyline in Patients Treated with a Combination of These Drugs as Compared with Those Treated with Amitriptyline AloneThe Journal of Clinical Pharmacology, 1995
- Metabolism of Drugs by Cytochrome P450 3A IsoformsClinical Pharmacokinetics, 1995
- Carbamazepine Coadministration with Fluoxetine or FluvoxamineTherapeutic Drug Monitoring, 1993
- Clinical Pharmacokinetics of Selective Serotonin Reuptake InhibitorsClinical Pharmacokinetics, 1993
- Fluoxetine Drug-Drug InteractionsJournal of Clinical Psychopharmacology, 1990
- Desmethyldiazepam Pharmacokinetics: Studies Following Intravenous and Oral Desmethyldiazepam, Oral Clorazepate, and Intravenous DiazepamThe Journal of Clinical Pharmacology, 1988
- Pharmacokinetic Model for Diazepam and its Major Metabolite Desmethyldiazepam Following Diazepam AdministrationJournal of Pharmaceutical Sciences, 1983